Diabetes Mellitus Negatively Impacts Survival of Patients with Colon Cancer, Particularly in Stage II Disease

Overview

Journal J Cancer Res Clin Oncol

Specialty Oncology

Date 2010 Apr 14

PMID 20387072

Citations 34

Authors

Yu-Chung Huang

Jen-Kou Lin

Wei-Shone Chen

Tzu-Chen Lin

Shung-Haur Yang

Jeng-Kai Jiang

Shih-Ching Chang

Yuan-Tzu Lan

Huann-Sheng Wang

Chun-Yu Liu

Ya-Wen Yang

Hao-Wei Teng

Affiliations

Soon will be listed here.

Abstract

Purpose: This retrospective study aimed to determine the effects of diabetes on overall survival (OS) and cancer-specific survival (CSS) in patients with newly diagnosed colon cancers, with particular focus on the impact of diabetes on survival at each stage of colon cancer.

Methods: From January 1999 to January 2008, 2762 consecutive patients diagnosed with colon cancer in Taipei Veterans General Hospital were enrolled. The general characteristics as well as presence of diabetes prior to colon cancer diagnosis were identified. Cox proportional hazard analyses were used for prognostic factors determination; and survival was analyzed using the Kaplan-Meier method with log-rank test.

Results: A total of 469 patients (17%) had diabetes at diagnosis of colon cancer. Patients with diabetes had baseline characteristics comparable to those without diabetes with the exception that the patients with diabetes were older (>65 years). Diabetes significantly and negatively impacted OS and CSS in multivariate analyses. After adjusting for possible confounding factors, the prognostic impact of diabetes on OS and CSS was particularly significant in patients with stage II colon cancer.

Conclusions: Diabetes is a poor prognostic factor in patients with newly diagnosed colon cancer, and it may directly impact the tumor behavior of stage II disease. Further study is required to elucidate the underlying pathophysiologic mechanisms.

Citing Articles

The impact of the incidence of diabetic complications on mortality in colorectal cancer patients with diabetes: A nationwide study.

Lee W, Han K, Chang Y, Park S, Kim W Int J Colorectal Dis. 2023; 38(1):219.

PMID: 37606760 DOI: 10.1007/s00384-023-04509-3.

Marked paper: Type 2 diabetes mellitus indicates increased postoperative complications and poor prognosis in colorectal cancer patients receiving curative surgery.

Liu D, Zhang X, Zhou H, Zhu Z, He Y, Wan X Front Oncol. 2023; 13:1128383.

PMID: 36845740 PMC: 9947490. DOI: 10.3389/fonc.2023.1128383.

The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus.

Tarhini Z, Manceur K, Magne J, Mathonnet M, Jost J, Christou N Sci Rep. 2022; 12(1):12374.

PMID: 35859114 PMC: 9300732. DOI: 10.1038/s41598-022-16677-3.

Diabetes and Colorectal Cancer Risk: Clinical and Therapeutic Implications.

Yu G, Li S, Wei R, Jiang Z J Diabetes Res. 2022; 2022:1747326.

PMID: 35296101 PMC: 8920658. DOI: 10.1155/2022/1747326.

Diabetes Mellitus as a Prognostic Factor for Locally Advanced Rectal Cancer.

Georgescu D, Patrascu T, Georgescu T, Tulin A, Mosoia L, Bacalbasa N In Vivo. 2021; 35(4):2495-2501.

PMID: 34182536 PMC: 8286501. DOI: 10.21873/invivo.12530.

References

El-Serag H, Hampel H, Javadi F . The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006; 4(3):369-80. DOI: 10.1016/j.cgh.2005.12.007. View

Jones R, Campbell C, Wood G, Petrik J, Moorehead R . Reversibility and recurrence of IGF-IR-induced mammary tumors. Oncogene. 2009; 28(21):2152-62. DOI: 10.1038/onc.2009.79. View

Coughlin S, Calle E, Teras L, Petrelli J, Thun M . Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol. 2004; 159(12):1160-7. DOI: 10.1093/aje/kwh161. View

Rajpathak S, Gunter M, Wylie-Rosett J, Ho G, Kaplan R, Muzumdar R . The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes Metab Res Rev. 2009; 25(1):3-12. PMC: 4153414. DOI: 10.1002/dmrr.919. View

Meyerhardt J, Catalano P, Haller D, Mayer R, Macdonald J, Benson 3rd A . Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003; 21(3):433-40. DOI: 10.1200/JCO.2003.07.125. View

Calle E, Kaaks R . Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004; 4(8):579-91. DOI: 10.1038/nrc1408. View

Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M . Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer. 2005; 92(11):2076-83. PMC: 2361795. DOI: 10.1038/sj.bjc.6602619. View

Barone B, Yeh H, Snyder C, Peairs K, Stein K, Derr R . Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008; 300(23):2754-64. PMC: 3093051. DOI: 10.1001/jama.2008.824. View

Sandhu M, Dunger D, Giovannucci E . Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst. 2002; 94(13):972-80. DOI: 10.1093/jnci/94.13.972. View

10.

Wolpin B, Meyerhardt J, Chan A, Ng K, Chan J, Wu K . Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol. 2008; 27(2):176-85. PMC: 2645084. DOI: 10.1200/JCO.2008.17.9945. View

11.

Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H . Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev. 1999; 15(5):314-22. DOI: 10.1002/(sici)1520-7560(199909/10)15:5<314::aid-dmrr56>3.0.co;2-e. View

12.

Friberg E, Orsini N, Mantzoros C, Wolk A . Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007; 50(7):1365-74. DOI: 10.1007/s00125-007-0681-5. View

13.

Will J, Galuska D, Vinicor F, Calle E . Colorectal cancer: another complication of diabetes mellitus?. Am J Epidemiol. 1998; 147(9):816-25. DOI: 10.1093/oxfordjournals.aje.a009534. View

14.

Compton C, Fielding L, Burgart L, Conley B, Cooper H, Hamilton S . Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000; 124(7):979-94. DOI: 10.5858/2000-124-0979-PFICC. View

15.

Goodwin P, Ennis M, Pritchard K, Trudeau M, Koo J, Madarnas Y . Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol. 2002; 20(1):42-51. DOI: 10.1200/JCO.2002.20.1.42. View

16.

Larsson S, Mantzoros C, Wolk A . Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007; 121(4):856-62. DOI: 10.1002/ijc.22717. View

17.

Polednak A . Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev. 2006; 30(5):466-72. DOI: 10.1016/j.cdp.2006.07.003. View

18.

Gunter M, Hoover D, Yu H, Wassertheil-Smoller S, Rohan T, Manson J . Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res. 2008; 68(1):329-37. PMC: 4225702. DOI: 10.1158/0008-5472.CAN-07-2946. View

19.

Gross C, Guo Z, McAvay G, Allore H, Young M, Tinetti M . Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc. 2007; 54(12):1898-904. DOI: 10.1111/j.1532-5415.2006.00973.x. View

20.

. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990; 264(11):1444-50. View